Patents by Inventor Ilias Stratikopoulos

Ilias Stratikopoulos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230114294
    Abstract: Methods for designing bivalent compounds which selectively degrade/disrupt EZH2 and compositions and methods of using such degraders/disruptors to treat EZH2-mediated cancer are provided.
    Type: Application
    Filed: November 1, 2022
    Publication date: April 13, 2023
    Inventors: Jian Jin, Ramon Parsons, Ilias Stratikopoulos, Xiaobao Yang, Anqi Ma
  • Patent number: 11510920
    Abstract: Methods for designing bivalent compounds which selectively degrade/disrupt EZH2 and compositions and methods of using such degraders/disruptors to treat EZH2-mediated cancer are provided.
    Type: Grant
    Filed: July 10, 2020
    Date of Patent: November 29, 2022
    Assignee: Icahn School of Medicine at Mount Sinai
    Inventors: Jian Jin, Ramon Parsons, Ilias Stratikopoulos, Xiaobao Yang, Anqi Ma
  • Publication number: 20220211690
    Abstract: Methods for assessing the efficacy of dihydroorotate dehydrogenase inhibitors in the treatment of cancer and methods of using such inhibitors to treat PTEN-mutant cancer are provided.
    Type: Application
    Filed: September 15, 2021
    Publication date: July 7, 2022
    Inventors: Ramon Parsons, Deepti Mathur, Ilias Stratikopoulos
  • Publication number: 20200338070
    Abstract: Methods for designing bivalent compounds which selectively degrade/disrupt EZH2 and compositions and methods of using such degraders/disruptors to treat EZH2-mediated cancer are provided.
    Type: Application
    Filed: July 10, 2020
    Publication date: October 29, 2020
    Inventors: Jian Jin, Ramon Parsons, Ilias Stratikopoulos, Xiaobao Yang, Anqi Ma
  • Publication number: 20190255041
    Abstract: Methods for designing bivalent compounds which selectively degrade/disrupt EZH2 and compositions and methods of using such degraders/disruptors to treat EZH2-mediated cancer are provided.
    Type: Application
    Filed: October 27, 2017
    Publication date: August 22, 2019
    Inventors: Jian Jin, Ramon Parsons, Ilias Stratikopoulos, Xiaobao Yang, Anqi Ma
  • Publication number: 20190192501
    Abstract: Methods for assessing the efficacy of dihydroorotate dehydrogenase inhibitors in the treatment of cancer and methods of using such inhibitors to treat PTEN-mutant cancer are provided.
    Type: Application
    Filed: August 2, 2017
    Publication date: June 27, 2019
    Inventors: Ramon Parsons, Deepti Mathur, Ilias Stratikopoulos